MAX Chat
Company Analysis PT Kalbe Farma Tbk.
1. Summary
Advantages
- Dividends (5.19%) are higher than the sector average (1.67%).
- Current debt level 1.9% is below 100% and has decreased over 5 years from 4.03%.
Disadvantages
- Price (0.0626 $) is higher than fair price (0.0074 $)
- The stock's return over the last year (-34.17%) is lower than the sector average (-31.57%).
- The company's current efficiency (ROE=0.002%) is lower than the sector average (ROE=14.34%)
Similar companies
2. Share price and performance
2.1. Share price
2.3. Market efficiency
| PT Kalbe Farma Tbk. | Healthcare | Index | |
|---|---|---|---|
| 7 days | 0% | -37.1% | 0.8% |
| 90 days | -32.7% | -35.6% | 11% |
| 1 year | -34.2% | -31.6% | 16.1% |
PTKFF vs Sector: PT Kalbe Farma Tbk. has slightly underperformed the "Healthcare" sector by -2.61% over the past year.
PTKFF vs Market: PT Kalbe Farma Tbk. has significantly underperformed the market by -50.24% over the past year.
Stable price: PTKFF is not significantly more volatile than the rest of the market on "OTC" over the last 3 months, with typical variations of +/- 5% per week.
Long period: PTKFF with weekly volatility of -0.6572% over the past year.
3. Summary of the report
4. Fundamental Analysis
4.1. Stock price and price forecast
Above fair price: The current price (0.0626 $) is higher than the fair price (0.0074 $).
Price is higher than fair: The current price (0.0626 $) is 88.2% higher than the fair price.
4.2. P/E
P/E vs Sector: The company's P/E (21.85) is lower than that of the sector as a whole (46.01).
P/E vs Market: The company's P/E (21.85) is lower than that of the market as a whole (45.94).
4.2.1 P/E Similar companies
4.3. P/BV
P/BV vs Sector: The company's P/BV (2.88) is lower than that of the sector as a whole (5.27).
P/BV vs Market: The company's P/BV (2.88) is lower than that of the market as a whole (4.35).
4.3.1 P/BV Similar companies
4.4. P/S
P/S vs Sector: The company's P/S indicator (2.17) is lower than that of the sector as a whole (4.28).
P/S vs Market: The company's P/S indicator (2.17) is lower than that of the market as a whole (12.92).
4.4.1 P/S Similar companies
4.5. EV/Ebitda
EV/Ebitda vs Sector: The company's EV/Ebitda (14.44) is lower than that of the sector as a whole (17.25).
EV/Ebitda vs Market: The company's EV/Ebitda (14.44) is lower than that of the market as a whole (27.36).
5. Profitability
5.1. Profitability and revenue
5.2. Earnings per share - EPS
5.3. Past profitability Net Income
Yield Trend: Negative and has fallen by -20% over the last 5 years.
Accelerating profitability: The return for the last year (1.32%) exceeds the average return for 5 years (-20%).
Profitability vs Sector: The return for the last year (1.32%) exceeds the return for the sector (-1.52%).
5.4. ROE
ROE vs Sector: The company's ROE (0.002%) is lower than that of the sector as a whole (14.34%).
ROE vs Market: The company's ROE (0.002%) is lower than that of the market as a whole (51.79%).
5.5. ROA
ROA vs Sector: The company's ROA (0.0016%) is lower than that of the sector as a whole (7.38%).
ROA vs Market: The company's ROA (0.0016%) is lower than that of the market as a whole (36.08%).
5.6. ROIC
ROIC vs Sector: The company's ROIC (16.21%) is higher than that of the sector as a whole (14.12%).
ROIC vs Market: The company's ROIC (16.21%) is higher than that of the market as a whole (10.95%).
7. Dividends
7.1. Dividend yield vs Market
High yield: The dividend yield of the company 5.19% is higher than the average for the sector '1.67%.
7.2. Stability and increase in payments
Dividend stability: The company's dividend yield 5.19% has been steadily paid over the past 7 years, DSI=0.86.
Weak dividend growth: The company's dividend yield 5.19% has been growing weakly or stagnant over the past 5 years. Growth over only 2 years.
7.3. Payout percentage
Dividend Coverage: Current payments from income (44.25%) are at a comfortable level.
Pay for your subscription
More functionality and data for company and portfolio analysis is available by subscription
